TapewireFind a company

person · Reporting owner

CAREY STEPHEN P.

Disclosed activity across 1 company

Tapewire entity
18119
SEC CIK
0001674236

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
ANI PHARMACEUTICALS INCANIP · Entity 4638SVP & CFOSeptember 29, 2026September 30, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ANI PHARMACEUTICALS INC

Report date September 29, 2026 · Filed September 30, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect168,993 Reported balance After 2026-09-29 transaction · row 1
1 source row

Row 1 · 2026-09-29 · Sale · Disposed 2,850 · Balance 168,993

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.

F2: The shares were sold in multiple trades at prices ranging from $72.57 to $73.86. The price reported above reflects the weighted average sales price.

Filing footnotes · ownership attribution and instrument terms

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.

F2: The shares were sold in multiple trades at prices ranging from $72.57 to $73.86. The price reported above reflects the weighted average sales price.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 29, 2026 Filed Sep 30, 2026 20:52 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 SaleCommon Stock 2,850 $73.00 $208,050.00
Disclosure

SEC source: 0001674236-26-000024 · wk-form4_1790801532.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 168,993

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.

F2 · price: The shares were sold in multiple trades at prices ranging from $72.57 to $73.86. The price reported above reflects the weighted average sales price.

Read SEC document
August 31, 2026 Filed Sep 1, 2026 22:18 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 SaleCommon Stock 2,850 $72.80 $207,480.00
Disclosure

SEC source: 0001674236-26-000022 · wk-form4_1788301118.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 171,843

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.

F2 · price: The shares were sold in multiple trades at prices ranging from $71.89 to $73.36. The price reported above reflects the weighted average sales price.

Read SEC document
July 29, 2026 Filed Jul 30, 2026 20:02 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 SaleCommon Stock 2,850 $81.36 $231,876.00
Disclosure

SEC source: 0001674236-26-000019 · wk-form4_1785441772.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 174,693

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.

F2 · price: The shares were sold in multiple trades at prices ranging from $80.61 to $81.88. The price reported above reflects the weighted average sales price.

Read SEC document
July 02, 2026 Filed Jul 7, 2026 01:40 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Exercise / conversionStock Option (right to buy) · Derivative 3,313 $49.51 Strike: $49.51 $164,026.63
Disclosure

SEC source: 0001674236-26-000017 · wk-form4_1783388415.xml · derivative · entry 3

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,313

Underlying: Common Stock · 3,313 shares

Expires 2027-03-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.

F2 · derivative.exercise_date: 25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021.

Read SEC document
July 02, 2026 Filed Jul 7, 2026 01:40 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 SaleCommon Stock 3,313 $86.00 $284,918.00
Disclosure

SEC source: 0001674236-26-000017 · wk-form4_1783388415.xml · nonDerivative · entry 2

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 177,543

F1 · kind: The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.

Read SEC document
July 02, 2026 Filed Jul 7, 2026 01:40 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Exercise / conversionCommon Stock 3,313 $49.51 $164,026.63
Disclosure

SEC source: 0001674236-26-000017 · wk-form4_1783388415.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 180,856

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.

Read SEC document
June 29, 2026 Filed Jun 30, 2026 20:14 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 SaleCommon Stock 2,850 $84.12 $239,742.00
Disclosure

SEC source: 0001674236-26-000015 · wk-form4_1782850477.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 177,543

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.

F2 · price: The shares were sold in multiple trades at prices ranging from $83.39 to $84.63. The price reported above reflects the weighted average sales price.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 22:33 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Exercise / conversionStock Option (right to buy) · Derivative 3,312 $49.51 Strike: $49.51 $163,977.12
Disclosure

SEC source: 0001674236-26-000013 · wk-form4_1781044421.xml · derivative · entry 3

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,626

Underlying: Common Stock · 3,312 shares

Expires 2027-03-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.

F2 · derivative.exercise_date: 25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 22:33 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 SaleCommon Stock 3,312 $80.00 $264,960.00
Disclosure

SEC source: 0001674236-26-000013 · wk-form4_1781044421.xml · nonDerivative · entry 2

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 180,393

F1 · kind: The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 22:33 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Exercise / conversionCommon Stock 3,312 $49.51 $163,977.12
Disclosure

SEC source: 0001674236-26-000013 · wk-form4_1781044421.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 183,705

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.

Read SEC document
March 07, 2026 Filed Mar 10, 2026 20:04 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Tax withholdingCommon Stock 5,150 $74.04 $381,306.00
Disclosure

SEC source: 0001674236-26-000010 · wk-form4_1773173079.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,393

F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 11,292 shares of restricted stock, the grant of which was previously reported.

Read SEC document
March 05, 2026 Filed Mar 5, 2026 22:46 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Exercise / conversionStock Option (right to buy) · Derivative 3,312 $49.51 Strike: $49.51 $163,977.12
Disclosure

SEC source: 0001674236-26-000008 · wk-form4_1772750785.xml · derivative · entry 4

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,938

Underlying: Common Stock · 3,312 shares

Expires 2027-03-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021.

Read SEC document
March 05, 2026 Filed Mar 5, 2026 22:46 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 SaleCommon Stock 4,000 $75.56 $302,240.00
Disclosure

SEC source: 0001674236-26-000008 · wk-form4_1772750785.xml · nonDerivative · entry 3

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 185,543

Read SEC document
March 05, 2026 Filed Mar 5, 2026 22:46 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 SaleCommon Stock 3,312 $75.42 $249,791.04
Disclosure

SEC source: 0001674236-26-000008 · wk-form4_1772750785.xml · nonDerivative · entry 2

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 189,543

F1 · price: The shares were sold in multiple trades at prices ranging from $75.41 to $75.56. The price reported above reflects the weighted average sales price.

Read SEC document
March 05, 2026 Filed Mar 5, 2026 22:46 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Exercise / conversionCommon Stock 3,312 $49.51 $163,977.12
Disclosure

SEC source: 0001674236-26-000008 · wk-form4_1772750785.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 192,855

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 28, 2026 Filed Mar 2, 2026 22:57 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Tax withholdingCommon Stock 2,773 $73.90 $204,924.70
Disclosure

SEC source: 0001674236-26-000006 · wk-form4_1772492247.xml · nonDerivative · entry 2

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 189,543

F2 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,079 shares of restricted stock, the grant of which was previously reported.

Read SEC document
February 26, 2026 Filed Mar 2, 2026 22:57 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 GrantCommon Stock 22,233 $77.15 $1,715,275.95
Disclosure

SEC source: 0001674236-26-000006 · wk-form4_1772492247.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 192,316

F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026.

Read SEC document
February 14, 2026 Filed Feb 17, 2026 21:03 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Tax withholdingCommon Stock 2,448 $77.36 $189,377.28
Disclosure

SEC source: 0001674236-26-000004 · wk-form4_1771362205.xml · nonDerivative · entry 2

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,083

F2 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 5,368 shares of restricted stock, the grant of which was previously reported on February 16, 2024.

Read SEC document
February 12, 2026 Filed Feb 17, 2026 21:03 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Tax withholdingCommon Stock 2,829 $76.70 $216,984.30
Disclosure

SEC source: 0001674236-26-000004 · wk-form4_1771362205.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 172,531

F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,202 shares of restricted stock, the grant of which was previously reported on February 18, 2025.

Read SEC document
February 11, 2026 Filed Feb 13, 2026 21:13 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Tax withholdingCommon Stock 5,503 $76.25 $419,603.75
Disclosure

SEC source: 0001674236-26-000002 · wk-form4_1771017231.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,360

F1 · shares: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 16,210 performance stock units, the grant of which was previously reported on April 6, 2023.

Read SEC document
August 12, 2025 Filed Aug 14, 2025 21:40 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Exercise / conversionStock Option (right to buy) · Derivative 50,000 $46.49 Strike: $46.49 $2,324,500.00
Disclosure

SEC source: 0001674236-25-000010 · wk-form4_1755207652.xml · derivative · entry 3

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 50,000 shares

Expires 2026-05-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: 25% of the total options vested on each of May 6, 2017, May 6, 2018, May 6, 2019, and May 6, 2020.

Read SEC document
August 12, 2025 Filed Aug 14, 2025 21:40 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 SaleCommon Stock 50,000 $86.07 $4,303,500.00
Disclosure

SEC source: 0001674236-25-000010 · wk-form4_1755207652.xml · nonDerivative · entry 2

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,863

Read SEC document
August 12, 2025 Filed Aug 14, 2025 21:40 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Exercise / conversionCommon Stock 50,000 $46.49 $2,324,500.00
Disclosure

SEC source: 0001674236-25-000010 · wk-form4_1755207652.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 230,863

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 23, 2025 Filed Mar 25, 2025 20:44 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Tax withholdingCommon Stock 6,210 $64.26 $399,054.60
Disclosure

SEC source: 0001674236-25-000008 · wk-form4_1742935483.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,863

F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 13,618 shares of restricted stock, the grant of which was previously reported.

Read SEC document
March 07, 2025 Filed Mar 14, 2025 21:17 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Tax withholdingCommon Stock 5,150 $60.62 $312,193.00
Disclosure

SEC source: 0001674236-25-000006 · wk-form4_1741987072.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 187,073

F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 11,292 shares of restricted stock, the grant of which was previously reported.

Read SEC document
February 28, 2025 Filed Mar 4, 2025 22:03 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Tax withholdingCommon Stock 1,861 $61.89 $115,177.29
Disclosure

SEC source: 0001674236-25-000004 · wk-form4_1741125785.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 192,223

F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,079 shares of restricted stock, the grant of which was previously reported.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 01:11 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Tax withholdingCommon Stock 1,730 $58.92 $101,931.60
Disclosure

SEC source: 0001674236-25-000002 · wk-form4_1739927467.xml · nonDerivative · entry 3

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,084

F3 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 5,368 shares of restricted stock, the grant of which was previously reported.

Read SEC document
February 12, 2025 Filed Feb 19, 2025 01:11 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 GrantCommon Stock 16,538 $0.00 $0.00
Disclosure

SEC source: 0001674236-25-000002 · wk-form4_1739927467.xml · nonDerivative · entry 2

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 195,814

F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting.

Read SEC document
February 12, 2025 Filed Feb 19, 2025 01:11 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 GrantCommon Stock 24,808 $0.00 $0.00
Disclosure

SEC source: 0001674236-25-000002 · wk-form4_1739927467.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 179,276

F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025.

Read SEC document
December 17, 2024 Filed Dec 18, 2024 22:59 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 SaleCommon Stock 7,500 $55.79 $418,425.00
Disclosure

SEC source: 0001674236-24-000015 · wk-form4_1734562739.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 154,468

F1 · price: The shares were sold in multiple trades at prices ranging from $55.29 to $56.30. The price reported above reflects the weighted average sales price.

Read SEC document
June 04, 2024 Filed Jun 6, 2024 11:34 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 SaleCommon Stock 5,000 $63.58 $317,900.00
Disclosure

SEC source: 0001674236-24-000013 · wk-form4_1717673646.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,968

F1 · price: The shares were sold in multiple trades at prices ranging from $64.85 to $62.72. The price reported above reflects the weighted average sales price.

Read SEC document
April 10, 2024 Filed Apr 12, 2024 01:12 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Tax withholdingCommon Stock 4,534 $66.96 $303,596.64
Disclosure

SEC source: 0001674236-24-000011 · wk-form4_1712884344.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 166,968

F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 9,942 shares of restricted stock, the grant of which was previously reported.

Read SEC document
March 23, 2024 Filed Mar 25, 2024 20:17 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Tax withholdingCommon Stock 6,210 $69.58 $432,091.80
Disclosure

SEC source: 0001674236-24-000009 · wk-form4_1711397817.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 171,502

F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 13,618 shares of restricted stock, the grant of which was previously reported.

Read SEC document
March 11, 2024 Filed Mar 11, 2024 22:39 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 SaleCommon Stock 7,787 $65.55 $510,437.85
Disclosure

SEC source: 0001674236-24-000007 · wk-form4_1710196767.xml · nonDerivative · entry 2

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 177,712

F2 · price: The shares were sold in multiple trades at prices ranging from $65.08 to $66.63. The price reported above reflects the weighted average sales price.

Read SEC document
March 07, 2024 Filed Mar 11, 2024 22:39 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Tax withholdingCommon Stock 4,216 $66.71 $281,249.36
Disclosure

SEC source: 0001674236-24-000007 · wk-form4_1710196767.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 185,499

F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 11,292 shares of restricted stock, the grant of which was previously reported.

Read SEC document
February 29, 2024 Filed Mar 1, 2024 21:55 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Tax withholdingCommon Stock 1,914 $67.67 $129,520.38
Disclosure

SEC source: 0001674236-24-000005 · wk-form4_1709330090.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 189,715

F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,079 shares of restricted stock, the grant of which was previously reported.

Read SEC document
February 14, 2024 Filed Feb 16, 2024 21:26 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 GrantCommon Stock 14,316 $0.00 $0.00
Disclosure

SEC source: 0001674236-24-000003 · wk-form4_1708118772.xml · nonDerivative · entry 2

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 191,629

F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting.

Read SEC document
February 14, 2024 Filed Feb 16, 2024 21:26 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 GrantCommon Stock 21,474 $0.00 $0.00
Disclosure

SEC source: 0001674236-24-000003 · wk-form4_1708118772.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 177,313

F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 14, 2024.

Read SEC document
August 14, 2023 Filed Aug 16, 2023 20:24 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 SaleCommon Stock 17,639 $61.37 $1,082,505.43
Disclosure

SEC source: 0001674236-23-000004 · wk-form4_1692217456.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 155,839

F1 · price: Reflects the weighted average price of sales on August 14, 2023. The shares were sold in multiple transactions at prices ranging from $60.50 to $61.86, inclusive.

Read SEC document
April 10, 2023 Filed Apr 12, 2023 20:43 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Tax withholdingCommon Stock 4,534 $38.50 $174,559.00
Disclosure

SEC source: 0001104659-23-044638 · tm2312564-2_4seq1.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 173,478

F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 9,942 shares of restricted stock, the grant of which was previously reported.

Read SEC document
March 28, 2023 Filed Mar 31, 2023 00:00 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Tax withholdingCommon Stock 1,420 $38.62 $54,840.40
Disclosure

SEC source: 0001104659-23-039338 · tm2311020-1_4seq1.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP AND CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 137,486

F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,113 shares of restricted stock, the grant of which was previously reported.

Read SEC document
March 23, 2023 Filed Mar 28, 2023 00:00 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Tax withholdingCommon Stock 4,224 $37.82 $159,751.68
Disclosure

SEC source: 0001104659-23-037249 · tm2310677-1_4seq1.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP AND CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,906

F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 13,617 shares of restricted stock, the grant of which was previously reported.

Read SEC document
March 07, 2023 Filed Mar 9, 2023 23:45 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Tax withholdingCommon Stock 864 $44.23 $38,214.72
Disclosure

SEC source: 0001104659-23-030708 · tm239061-3_4seq1.xml · nonDerivative · entry 2

CAREY STEPHEN P. · CIK 0001674236 · SVP AND CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,130

F2 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 2,822 shares of restricted stock, the grant of which was previously reported.

Read SEC document
March 07, 2023 Filed Mar 9, 2023 23:45 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Tax withholdingCommon Stock 2,639 $44.23 $116,722.97
Disclosure

SEC source: 0001104659-23-030708 · tm239061-3_4seq1.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP AND CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,994

F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 8,468 shares of restricted stock, the grant of which was previously reported.

Read SEC document
February 28, 2023 Filed Apr 7, 2023 00:00 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 GrantCommon Stock 16,210 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-042847 · tm2311710-1_4seq1.xml · nonDerivative · entry 2

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 178,012

F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting.

Read SEC document
February 28, 2023 Filed Apr 7, 2023 00:00 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 GrantCommon Stock 24,316 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-042847 · tm2311710-1_4seq1.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,802

F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 28, 2023.

Read SEC document
April 27, 2022 Filed Apr 29, 2022 22:34 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 GrantCommon Stock 11,291 $0.00 $0.00
Disclosure

SEC source: 0001415889-22-004405 · form4-04292022_030455.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SENIOR VICE PRESIDENT AND CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,633

F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of March 7, 2022.

Read SEC document
April 10, 2022 Filed Apr 12, 2022 21:11 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Tax withholdingCommon Stock 4,534 $29.91 $135,611.94
Disclosure

SEC source: 0001415889-22-004020 · form4-04122022_020415.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SENIOR VICE PRESIDENT AND CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,342

F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 9,942 shares of restricted stock, the grant of which was previously reported.

Read SEC document
April 06, 2022 Filed Apr 8, 2022 21:37 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Tax withholdingCommon Stock 912 $29.69 $27,077.28
Disclosure

SEC source: 0001415889-22-003970 · form4-04082022_020427.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SENIOR VICE PRESIDENT AND CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 139,876

F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 2,000 shares of restricted stock, the grant of which was previously reported.

Read SEC document
March 28, 2022 Filed Mar 30, 2022 20:10 UTC ANI PHARMACEUTICALS INC ANIP · Entity 4638 Tax withholdingCommon Stock 1,420 $28.17 $40,001.40
Disclosure

SEC source: 0001415889-22-003471 · form4-03302022_010309.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SENIOR VICE PRESIDENT AND CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,788

F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,113 shares of restricted stock, the grant of which was previously reported.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.